Who owns the OPUL trademark?

The OPUL trademark is owned by Revance Therapeutics, Inc..

What is the serial number for OPUL?

The USPTO serial number for OPUL is 90619121.

What is the registration number for OPUL?

OPUL is registered under USPTO registration number 7190186.

OPU

USPTO Trademark Record

REGISTERED

OPUL

Q: What class is the OPUL trademark registered in?

The OPUL trademark is registered in Class 035 (Advertising, business management & retail services), Class 036 (Insurance, financial & real estate services), Class 042 (Scientific, technology & SaaS services).

SN 90619121·Reg 7190186·Filed Apr 01, 2021

Owner Revance Therapeutics, Inc.

Advertising; business management, organization and administration; office functions.; Financial, monetary and banking services; insurance services; real estate services.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

OPUL (Serial No. 90619121), Registration No. 7190186, is a registered US trademark filed on Apr 01, 2021 by Revance Therapeutics, Inc.. This trademark covers Class 035 (Advertising, business management & retail services), Class 036 (Insurance, financial & real estate services), Class 042 (Scientific, technology & SaaS services).

early section 8: October 10, 2029

Mark Intelligence

OPUL (Reg. #7190186) is a registered US trademark that has been protecting its owner, Revance Therapeutics, Inc., since 2021. The mark covers Class 035 (Advertising, business management & retail services), Class 036 (Insurance, financial & real estate services) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Advertising; business management, organization and administration; office functions.; Financial, monetary and banking se.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 01, 2021

SERIAL

90619121

REG#

7190186

REGISTERED

Oct 10, 2023

Owner

Applicant

Revance Therapeutics, Inc.

Entity

Corporation

State

Address

UNIT 8, THE OLIVIA CENTRE, 373-375 ANTRIM ROAD, GLENGORMLEY, BT365EB

Country

Attorney

NameJennifer Waitman

Law firm

Jennifer Waitman Kilpatrick Townsend & Stockton LLP

Address

3 Times Square, New York, NY 10036, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 01, 2021

Serial Number90619121

Registration No.7190186

Registration DateOct 10, 2023

Status DateOct 10, 2023

Published for OppositionDec 21, 2021

Mark TypeDesign with words

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

First use anywhere: Mar 31, 2021

First use in commerce: Mar 31, 2021

Advertising; business management, organization and administration; office functions.

Class 036Insurance, financial & real estate services

US codes: 100, 101, 102

First use anywhere: Mar 31, 2021

First use in commerce: Mar 31, 2021

Financial, monetary and banking services; insurance services; real estate services.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Mar 31, 2021

First use in commerce: Mar 31, 2021

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

41 events

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 20, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 20, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 20, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Aug 04, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Aug 04, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Aug 04, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Aug 04, 2025

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Aug 04, 2025

TEAS CHANGE OF OWNER ADDRESS RECEIVED

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 10, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

REGISTERED-PRINCIPAL REGISTER

Oct 10, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 08, 2023

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 07, 2023

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 06, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 05, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 05, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jun 01, 2023

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jun 01, 2023

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

NON-FINAL ACTION E-MAILED

Mar 03, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 03, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

SU - NON-FINAL ACTION - WRITTEN

Mar 03, 2023

SU - NON-FINAL ACTION - WRITTEN

STATEMENT OF USE PROCESSING COMPLETE

Mar 02, 2023

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 27, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

USE AMENDMENT FILED

Feb 06, 2023

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Feb 06, 2023

TEAS STATEMENT OF USE RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 10, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 GRANTED

Aug 08, 2022

SOU EXTENSION 1 GRANTED

SOU EXTENSION 1 FILED

Aug 08, 2022

SOU EXTENSION 1 FILED

SOU TEAS EXTENSION RECEIVED

Aug 08, 2022

SOU TEAS EXTENSION RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 15, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Dec 21, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 21, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 01, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 17, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINER'S AMENDMENT ENTERED

Nov 17, 2021

EXAMINER'S AMENDMENT ENTERED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 17, 2021

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT E-MAILED

Nov 17, 2021

EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Nov 17, 2021

EXAMINERS AMENDMENT -WRITTEN

ASSIGNED TO EXAMINER

Nov 15, 2021

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jul 10, 2021

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 09, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 05, 2021

NEW APPLICATION ENTERED

Other Marks in Class 035 — Advertising, business management & retail services

Recently filed and registered marks in the same international class.

OPU

OPUL

90619132

Revance Therapeutics, Inc.

REGISTERED

OPU

OPUL

90078705

Revance Therapeutics, Inc.

REGISTERED

OPU

OPUL

77934326

Opul LLC

ABANDONED

OPUL

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Revance Therapeutics, Inc.

Other Marks in Class 035 — Advertising, business management & retail services

Other Marks by Jennifer Waitman

Resources

Company